BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 21034775)

  • 1. Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid.
    Gutierrez JA; Klepper AL; Garber J; Walewski JL; Bateman K; Khaitova V; Syder A; Tscherne DM; Gauthier A; Jefferson D; Rice CM; Schiano TD; Branch AD
    J Virol Methods; 2011 Jan; 171(1):169-75. PubMed ID: 21034775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic variation of core, NS3, and NS5 proteins among genotypes of hepatitis C virus.
    Neville JA; Prescott LE; Bhattacherjee V; Adams N; Pike I; Rodgers B; El-Zayadi A; Hamid S; Dusheiko GM; Saeed AA; Haydon GH; Simmonds P
    J Clin Microbiol; 1997 Dec; 35(12):3062-70. PubMed ID: 9399495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative assay of anti-HCV core antibody with JCC-2 ELISA: anti-HCV core IgG antibody].
    Nakashima T; Mizuno K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):247-52. PubMed ID: 7563711
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection.
    Sillanpää M; Melén K; Porkka P; Fagerlund R; Nevalainen K; Lappalainen M; Julkunen I
    Virol J; 2009 Jun; 6():84. PubMed ID: 19549310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA.
    Rodr Guez-L Pez M; Riezu-Boj JI; Ruiz M; Berasain C; Civeira MP; Prieto J; Borr S-Cuesta F
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():727-738. PubMed ID: 10092013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
    Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
    Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
    Park YM; Byun BH; Choi JY; Bae SH; Kim BS; So HS; Ryu WS
    J Korean Med Sci; 1999 Apr; 14(2):165-70. PubMed ID: 10331562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of core and NS4B synthetic peptide-based immunoassays for the detection of hepatitis C virus antibodies in clinical samples from Cameroon, Central Africa.
    Njouom R; Nerrienet E; Budkowska A; Maillard P; Rousset D; Kalinina O; Mavromara P;
    J Clin Virol; 2010 Sep; 49(1):61-4. PubMed ID: 20621554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of immune responses to the host-encoded GOR and hepatitis C virus core-derived epitopes with relation to hepatitis C viremia, genotypes, and liver disease severity.
    Quiroga JA; Pardo M; Navas S; Martín J; Carreño V
    J Infect Dis; 1996 Feb; 173(2):300-5. PubMed ID: 8568289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of an anti-HCV core peptide ELISA.
    Bresters D; Reesink HW; Cuypers HT; Jansen PL; Mauser-Bunschoten EP; van der Poel CL; Lelie PN
    J Med Virol; 1992 Jul; 37(3):187-91. PubMed ID: 1279109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
    Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
    Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
    J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays.
    Ali A; Nisar M; Idrees M; Rafique S; Iqbal M
    Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of immunodominant epitopes in the core and non-structural region of hepatitis C virus by enzyme immunoassay using synthetic peptides.
    Park HJ; Byun SM; Ha YJ; Ahn JS; Moon HM
    J Immunoassay; 1995 May; 16(2):167-81. PubMed ID: 7543117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections.
    Tuveri R; Rothschild C; Pol S; Reijasse D; Persico T; Gazengel C; Bréchot C; Thiers V
    J Med Virol; 1997 Jan; 51(1):36-41. PubMed ID: 8986947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG.
    Logan M; Law J; Wong JAJ; Hockman D; Landi A; Chen C; Crawford K; Kundu J; Baldwin L; Johnson J; Dahiya A; LaChance G; Marcotrigiano J; Law M; Foung S; Tyrrell L; Houghton M
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence of HCV RNA, and acute HCV infection.
    Zhang ZX; Chen M; Sönnerborg A; Sällberg M
    Clin Diagn Lab Immunol; 1994 May; 1(3):290-4. PubMed ID: 7496964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoreactivity studies on synthetic peptides deriving from immunodominant region of hepatitis C virus NS5a gene].
    Shi LL; Dou XG; Feng GH; Fields H; Khudyakov Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Dec; 18(4):344-7. PubMed ID: 15650785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a multiple peptide assay for typing of antibodies to the hepatitis C virus: relation to genomic typing by the polymerase chain reaction.
    Zhang ZX; Yun ZB; Chen M; Sönnerborg A; Sällberg M
    J Med Virol; 1995 Jan; 45(1):50-5. PubMed ID: 7536231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.
    Bresters D; Cuypers HT; Reesink HW; Schaasberg WP; van der Poel CL; Mauser-Bunschoten EP; Houghton M; Choo QL; Kuo G; Lesniewski R
    Vox Sang; 1992; 62(4):213-7. PubMed ID: 1379394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.